P50 Suppression in Individuals at Risk for Schizophrenia: The Convergence of Clinical, Familial, and Vulnerability Marker Risk Assessment

Ongoing longitudinal follow-up studies will determine whether it is possible to improve the predictive validity of the clinical and familial variables by using P50 suppression alone or in combination with other measures in determining which individuals are at greatest risk for schizophrenia.